Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response

Respiratory syncytial virus (RSV) is one of the most important pathogens of infancy and early childhood. Here a fruit-based edible subunit vaccine against RSV was developed by expressing the RSV fusion (F) protein gene in transgenic tomato plants. The F-gene was expressed in ripening tomato fruit under the control of the fruit-specific E8 promoter. Oral immunization of mice with ripe transgenic tomato fruits led to the induction of both serum and mucosal RSV-F specific antibodies. The ratio of immunoglobulin subclasses produced in response to immunization suggested that a type 1 T-helper cell immune response was preferentially induced. Serum antibodies showed an increased titer when the immunized mice were exposed to inactivated RSV antigen.

[1]  C. Hall,et al.  Respiratory Syncytial Virus , 1983 .

[2]  C. Koncz,et al.  The promoter of TL-DNA gene 5 controls the tissue-specific expression of chimaeric genes carried by a novel type of Agrobacterium binary vector , 1986, Molecular and General Genetics MGG.

[3]  P. Paradiso,et al.  Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. , 1994, Vaccine.

[4]  J. Schlesinger,et al.  Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. , 1987, The Journal of infectious diseases.

[5]  J. Melero,et al.  Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. , 1996, The Journal of general virology.

[6]  D. M. Lam,et al.  Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Walsh,et al.  Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. , 1993, The Journal of infectious diseases.

[8]  P. Openshaw,et al.  Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. , 1993, Vaccine.

[9]  M. Estes,et al.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[11]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[12]  L. Anderson,et al.  Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV , 1997, Journal of virology.

[13]  S. Levine,et al.  Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. , 1987, The Journal of general virology.

[14]  P. Collins,et al.  The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. , 1988, The Journal of general virology.

[15]  E. Simões,et al.  Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia. , 1998, The Journal of infectious diseases.

[16]  C. R. Bird,et al.  The tomato polygalacturonase gene and ripening-specific expression in transgenic plants , 1988, Plant Molecular Biology.

[17]  E. Wang,et al.  Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer. , 1997, Pediatrics.

[18]  T. Braciale,et al.  Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection , 1997, Journal of virology.

[19]  R. Fischer,et al.  Organization of Ripening and Ethylene Regulatory Regions in a Fruit-Specific Promoter from Tomato (Lycopersicon esculentum). , 1992, Plant physiology.

[20]  R. Chanock,et al.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.

[21]  F. L. Lyon,et al.  Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin , 1986, Infection and immunity.

[22]  J. Devincenzo.  Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases). , 1997, Advances in pediatric infectious diseases.

[23]  P. Piedra,et al.  Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. , 1998, The Pediatric infectious disease journal.

[24]  J. Mills.  Prevention and treatment of respiratory syncytial virus infections. , 1999, Advances in experimental medicine and biology.

[25]  B. Moss,et al.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Braciale,et al.  Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection , 1997, The Journal of experimental medicine.

[27]  E. Walsh,et al.  Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. , 1996, Vaccine.

[28]  C. Hall.  Prospects for a respiratory syncytial virus vaccine. , 1994, Science.

[29]  M. Levine,et al.  Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato , 1998, Nature Medicine.

[30]  Y. Chupeau,et al.  Re-evaluation of Conditions for Plant Regeneration and Agrobacterium-Mediated Transformation from Tomato (Lycopersicon esculentum) , 1993 .

[31]  P. Benfey,et al.  The CaMV 35S enhancer contains at least two domains which can confer different developmental and tissue‐specific expression patterns , 1989, The EMBO journal.

[32]  S. Cordes,et al.  Regulation of gene expression by ethylene during Lycopersicon esculentum (tomato) fruit development. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Paradiso,et al.  Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old. , 1994, The Pediatric infectious disease journal.

[34]  W. Langridge,et al.  Efficacy of a food plant-based oral cholera toxin B subunit vaccine , 1998, Nature Biotechnology.

[35]  A. N. Adams,et al.  Characteristics of the microplate method of enzyme-linked immunosorbent assay for the detection of plant viruses. , 1977, The Journal of general virology.

[36]  S. Korban,et al.  Enhanced expression of the human respiratory syncytial virus-F gene in apple leaf protoplasts , 1999, Plant Cell Reports.

[37]  P. Paradiso,et al.  Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. , 1993, The Journal of infectious diseases.

[38]  P. Hiatt,et al.  Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. , 1996, The Pediatric infectious disease journal.

[39]  E. Walsh,et al.  Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. , 1998, The Journal of infectious diseases.

[40]  S. Strobel,et al.  Immune responses to dietary antigens: oral tolerance. , 1998, Immunology today.

[41]  H. Mason,et al.  Oral immunization with a recombinant bacterial antigen produced in transgenic plants , 1995, Science.

[42]  C. Arntzen.  High-tech herbal medicine: Plant-based vaccines , 1997, Nature Biotechnology.

[43]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[44]  R. Fischer,et al.  Regulation of Gene Expression by Ethylene , 1988 .

[45]  K. Cross,et al.  Respiratory syncytial virus or influenza? , 1993, The Lancet.

[46]  R. M. Hendry,et al.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. , 1985, The Journal of infectious diseases.